Delivery Method: VIA UPS Reference #: 320-25-55 Product: Drugs Recipient: Recipient Name Mr. Frank M. Bardani Recipient Title President Advanced Pharmaceutical Technology 132 South Central Avenue Elmsford, NY 10523 United States Issuing Office: Center for …
Recipient: Recipient Name Kari Kenner, CEO Recipient Title Shannon Kenner, CEO Waxhead Sun Defense Company 614 Santa Maria Dr Fernandina Beach, FL 32034 United States mac@gowaxhead.com Issuing Office: Center for Drug Evaluation and Research (CDER) United …
Delivery Method: Via Electronic Mail - Delivery and Read Receipt Requested Product: Drugs Recipient: Recipient Name Mr. Mark L’Hommedieu Recipient Title Managing Partner ProRx, LLC 619 Jeffers Circle Exton, PA 19341-2540 United States Issuing Office: …
Reference #: FEI 3009728473 Product: Drugs Recipient: Recipient Name Amanda Biggart and Dakota Flowers Recipient Title Chief Operating Officer/Compliance Manager Safe Chain Solutions, LLC 822 Chesapeake Dr Cambridge, MD 21613-9408 United States 855-437- …
Summary Company Announcement Date: March 15, 2025 FDA Publish Date: March 15, 2025 Product Type: Animal & Veterinary Reason for Announcement: Recall Reason Description Possible Bird Flu Health Risk Company Name: Savage Pet Brand Name: Product …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
For Immediate Release: March 14, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA posted information on the flu vaccine composition for the 2025-2026 U.S. flu season. …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
FDA News Release Ads Helped Reduce Youth E-Cigarette Use to Lowest Level in a Decade For Immediate Release: March 14, 2025 Today, a study co-authored by U.S. Food and Drug Administration scientists was released showing the agency’s youth e-cigarette …
Summary Company Announcement Date: March 13, 2025 FDA Publish Date: March 13, 2025 Product Type: Drugs Reason for Announcement: Recall Reason Description Mislabeling of infusion bag Company Name: Dr. Reddy’s Laboratories Ltd. Brand Name: Brand Name(s) …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
STN: 125771 Proper Name: antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl Tradename: ALTUVIIIO Manufacturer: Bioverativ Therapeutics Inc., a Sanofi Company Indication: For use in adults and children with hemophilia A (congenital factor …
On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.
AUDIENCE: Patient, Health Professional, Pharmacy, Immunology ISSUE: As a precautionary measure, the following lots of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) have been voluntarily withdrawn by the manufacturers due to a …
For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement Summary Company …
[3/11/2025] FDA is alerting the public and industry to the results of new agency testing of 95 acne products containing benzoyl peroxide for possible benzene contamination. FDA has concluded that a limited number of products should be recalled at the …
Reference #: FEI 3006731547 Product: Drugs Recipient: Recipient Name Mr. Young-Gi Son Recipient Title President Natuzen Co., Ltd. 289 Namdongdong-Ro Namdong-gu Incheon 21639 South Korea Issuing Office: Center for Drug Evaluation and Research (CDER) United …
